Gastroenterology · Pancreatic Adenocarcinoma
The facts most likely to be tested
Pancreatic adenocarcinoma most commonly arises in the pancreatic head, leading to painless obstructive jaundice and conjugated hyperbilirubinemia.
Courvoisier sign, defined as a palpable, nontender gallbladder in the presence of jaundice, is a classic physical exam finding indicating malignancy rather than gallstones.
Trousseau syndrome, characterized by migratory superficial thrombophlebitis, serves as a paraneoplastic manifestation of underlying pancreatic malignancy.
Double duct sign, showing simultaneous dilation of the common bile duct and the pancreatic duct on imaging, is highly suggestive of a periampullary tumor.
CA 19-9 is the most useful tumor marker for monitoring treatment response and detecting recurrence, though it lacks sufficient sensitivity for initial screening.
CT scan with pancreatic protocol is the diagnostic test of choice for staging and determining the resectability of the tumor.
Whipple procedure (pancreaticoduodenectomy) is the definitive surgical treatment for tumors localized to the pancreatic head.
Vignette unlocked
A 68-year-old male presents with a two-month history of progressive fatigue, weight loss, and dark urine. Physical examination reveals scleral icterus and a palpable, nontender gallbladder in the right upper quadrant. Laboratory studies demonstrate a total bilirubin of 12.4 mg/dL with a direct fraction of 10.2 mg/dL and elevated alkaline phosphatase. An abdominal ultrasound shows intrahepatic and extrahepatic biliary duct dilation but no evidence of cholelithiasis.
What is the most likely diagnosis and the most appropriate next step in management?
Pancreatic adenocarcinoma; CT scan of the abdomen with pancreatic protocol.
The patient presents with the classic triad of painless jaundice, weight loss, and a palpable gallbladder (Courvoisier sign), which is highly suspicious for pancreatic head cancer; a CT scan is required to confirm the diagnosis and assess resectability.
Full handout
High yield triage
Etiology / Epidemiology
Primarily adenocarcinoma of the ductal epithelium. Major risk factors include smoking, chronic pancreatitis, and hereditary syndromes (BRCA2, Peutz-Jeghers).
Clinical Manifestations
Painless jaundice is the hallmark. Look for Courvoisier's sign (palpable, non-tender gallbladder) and weight loss.
Diagnosis
CT scan with contrast is the initial diagnostic test of choice. CA 19-9 is the tumor marker used for monitoring.
Treatment
Surgical resection via Whipple procedure (pancreaticoduodenectomy) is the only curative option. Adjuvant chemotherapy is standard post-op.
Prognosis
Extremely poor prognosis with a 5-year survival rate < 5%. Most patients present with metastatic disease at diagnosis.
Full handout
Epidemiology & Etiology
Incidence peaks in the 7th decade of life. Smoking is the most significant modifiable risk factor, doubling the risk. Chronic pancreatitis and diabetes mellitus (new-onset in elderly) are strong clinical associations.
Pertinent Anatomy
Approximately 70% of tumors arise in the pancreatic head, leading to early obstruction of the common bile duct. Tumors in the body or tail are often diagnosed later due to lack of early obstructive symptoms.
Pathophysiology
Most are ductal adenocarcinomas originating from the exocrine pancreas. Genetic mutations, specifically KRAS (90%), CDKN2A, and TP53, drive malignant transformation. Local invasion into the superior mesenteric vessels often precludes surgical resection.
Clinical Manifestations
Patients present with painless jaundice, dark urine, and clay-colored stools. Courvoisier's sign (palpable, non-tender gallbladder) suggests malignancy rather than stones. Trousseau's syndrome (migratory thrombophlebitis) is a classic paraneoplastic red flag.
Diagnosis
CT scan with pancreatic protocol is the gold standard for staging and resectability. Endoscopic ultrasound (EUS) with fine-needle aspiration is the most sensitive method for tissue biopsy. CA 19-9 levels correlate with tumor burden but lack sufficient sensitivity for screening.
Treatment
Only 15-20% of patients are candidates for the Whipple procedure. Vascular involvement of the SMA or celiac axis renders the tumor unresectable. Gemcitabine or FOLFIRINOX are the primary systemic chemotherapy regimens. Palliative stenting is required for biliary obstruction.
Prognosis
High rate of recurrence even after curative-intent surgery. Cachexia and severe pain are common terminal complications. Close monitoring of CA 19-9 is required to detect early recurrence.
Differential Diagnosis
Choledocholithiasis: typically presents with biliary colic and fever
Chronic pancreatitis: usually associated with alcohol use and calcifications
Ampullary carcinoma: often presents with intermittent jaundice and occult blood
Cholangiocarcinoma: presents with jaundice but usually lacks a pancreatic mass
Pancreatic pseudocyst: history of acute pancreatitis with fluid collection